Investors in Asia are still digesting the impact of US President Donald Trump’s first few days in office, which have sent mixed signals to investors. Trump has reiterated a tariff threat against China but have largely spared the world’s second-largest economy from a feared escalation of the trade war.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.